Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

False advertising over Covid-19 cures targeted by Commerce Commission

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)

The Global Science and Politics of Covid-19 / SARS-CoV-2

COVID-19 Lockdown Exit Analysis

Coronavirus: What do we know about the artemisia plant?

Pharmacists Help Study Sweet Wormwood for COVID-19

COVID-19 Lockdown Exit Analysis

Artemisia annua ▻ teemana online store

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

Another Malaria Cure Draws Notice in Coronavirus Outbreak, This Time in Africa - WSJ